Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct...

Area of Science:

• Immunology
• Cell Biology
• Metabolomics

Background:

• Mast cells are crucial inflammatory cells found in various tissues.
• Two primary phenotypes exist: connective tissue mast cells (CTMC) and mucosal mast cells (MMC).
• These phenotypes differ in their mediator release capabilities, influencing health and disease.

Purpose of the Study:

• To comprehensively understand the lipid mediator production capacity of mast cell phenotypes.
• To investigate the distinct metabolic profiles of connective tissue-like mast cells (CTLMCs) and mucosal-like mast cells (MLMCs).
• To identify specific lipid mediators associated with each mast cell phenotype.

Main Methods:

• Metabolic profiling using liquid chromatography-tandem mass spectrometry (LC-MS/MS) to characterize 90 lipid mediators (oxylipins).
• Analysis of mRNA expression patterns for enzymes in oxylipin biosynthesis pathways (COX, LO, CYP).
• Multivariate analysis of oxylipin profiles from in vitro-derived murine CTLMCs and MLMCs, with and without calcium ionophore stimulation.

Main Results:

• Distinct mRNA expression patterns for oxylipin biosynthesis enzymes were observed between CTLMCs and MLMCs.
• Lipoxygenase (LO) and cyclooxygenase (COX) pathways were predominant in oxylipin production for both phenotypes.
• CTLMCs predominantly produced 5-LO products (90%) compared to MLMCs (58%), while both showed distinct oxylipin profiles at baseline and after stimulation.

Conclusions:

• Mast cell phenotypes (CTLMC and MLMC) exhibit specific and distinct oxylipin profiles.
• These differences are dependent on time and biosynthetic pathways, indicating phenotype-specific mediator secretion.
• The identified phenotype-specific lipid mediators may play significant roles in mast cell-mediated inflammatory regulation.